Loading people...
Ariel Krause is a biomedical engineer and technology professional currently operating within the broader startup ecosystem, though her specific geographic location and present corporate role remain undisclosed in public datasets. She earned a Bachelor of Science in Biomedical Engineering from Washington University in St. Louis, an institution known for its rigorous medical and technical research programs. Following her formal academic training, Krause transitioned her focus toward the technology sector to support early-stage innovation across various health and engineering disciplines. While her exact professional trajectory, specific venture capital involvement, and direct company affiliations are not widely documented, her core expertise bridges the critical gap between clinical healthcare requirements and emerging technological solutions. Krause ultimately leverages her specialized academic engineering background to evaluate, support, and advance new developments within the modern health-tech and biomedical innovation landscapes.
Ariel Krause is a key member of the investment team at OurCrowd, where she holds the position of Investment Associate. OurCrowd is renowned as a leading global venture investing platform, empowering accredited investors to participate in the growth of high-potential startups. In her capacity, Ariel plays a crucial role in the rigorous due diligence process and strategic analysis that underpins OurCrowd's investment decisions.
Her work involves meticulously researching market trends, assessing the viability of innovative technologies, and evaluating the business models of prospective portfolio companies. Ariel's investment focus aligns with OurCrowd's broader strategy, which typically targets disruptive technologies and innovative startups across various sectors. These often include artificial intelligence (AI), cybersecurity, health tech, fintech, enterprise software, agritech, and deep tech, among others. She is dedicated to uncovering companies with strong leadership, scalable solutions, and significant market potential, helping to shape OurCrowd's diverse and impactful portfolio.
While specific details of Ariel Krause's career background prior to OurCrowd are not publicly detailed, her role as an Investment Associate suggests a strong foundation in finance, venture capital, or the startup ecosystem. Professionals in this position typically possess sharp analytical skills, a deep understanding of technology trends, and a passion for identifying and nurturing early-stage companies. Her expertise contributes to OurCrowd's mission of connecting investors with groundbreaking innovations, particularly within the vibrant Israeli tech scene and increasingly across global markets.
At OurCrowd, Ariel contributes to a collaborative environment where investment professionals work together to identify, vet, and support the next generation of industry leaders. Her contributions help ensure that OurCrowd continues to back companies poised for significant growth and market disruption, providing value to both the startups and the platform's extensive network of investors. Her work is integral to OurCrowd's success in democratizing access to venture capital opportunities and fostering innovation worldwide.
Ariel Krause is an Investment Associate at OurCrowd, a global venture investing platform. She is responsible for identifying, evaluating, and conducting due diligence on early-stage technology companies for potential investment.
Ariel Krause's investment focus at OurCrowd aligns with the platform's strategy of targeting disruptive technologies. This includes sectors such as AI, cybersecurity, health tech, fintech, enterprise software, agritech, and other deep tech innovations.
Ariel Krause works at OurCrowd, a leading global venture investing platform that connects accredited investors with high-potential early-stage companies, primarily in the technology sector.
